LOX and gastric cancer: This approach enables targeted study of collagen-ECM crosstalk, allowing researchers to manipulate crosslinking enzymes (e.g., LOX inhibition) or stiffness parameters to dissect their roles in gastric cancer progression, offering a physiologically relevant alternative to synthetic or natural hydrogels for evaluating therapeutic strategies.